Patrick Vizeli

12PUBLICATIONS
27CO-AUTHORS
Biologically active moleculesPsychological methodology, design and analysisMolecular medicinePharmaceutical delivery technologiesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 28, 2026
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

|Dec 26, 2025
The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

Kurt Stocker, Matthias Hartmann, Yasmin Schmid

|Sep 25, 2025
Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants.

Isabelle Straumann, Patrick Vizeli, Isidora Avedisian

|May 26, 2025
Absolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double-Blind, Placebo-Controlled, Crossover Study.

Denis Arikci, Friederike Holze, Lorenz Mueller

|Sep 11, 2024
Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.

Mihai Avram, Lydia Fortea, Lea Wollner

|Sep 04, 2024
Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.

Patrick Vizeli, Erich Studerus, Friederike Holze

Pageof 2

Frequent Collaborators

12 joint publications

Matthias E Liechti

9 joint publications

Friederike Holze

5 joint publications

Anne Eckert

3 joint publications

Stefan Borgwardt